Hjem › Blodkreft › Alabama › Birmingham
Kliniske studier for Blodkreft i Birmingham, AL
11 studier for Blodkreft søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- University of Alabama Birmingham, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 16, Birmingham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekruttererFase 1/2
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- University of Alabama at Birmingham, Birmingham
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
RekruttererFase 3
- Children's Hospital of Alabama, Birmingham
Cognitive Training Intervention and Attitudes Towards Genetics
Rekrutterer
- University of Alabama at Birmingham, Birmingham
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
Diet and Cognitive Training in Hematologic Cancer Survivors
Rekrutterer
- University of Alabama at Birmingham, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Rekrutterer
- University of Alabama at Brimingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
Blodkreft-studier i andre byer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Seattle, WA18 studier
- Baltimore, MD18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Columbus, OH13 studier
- Edison, NJ13 studier
Andre studier i Birmingham
- Kreft (alle typer)31 studier
- Brystkreft24 studier
- Eggstokkreft23 studier
- Fedme23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Type 2-diabetes16 studier
- Endometriekreft16 studier
- Overvekt16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.